Home » Newsletters » BioWorld

BioWorld

Oct. 26, 1992

View Archived Issues

LIDAK TO GO IT ALONE ON LIDAKOL TRIALS

NIH PANEL PROBES VACCINE FUNDING

PHARMAKINETICS REORGANIZATION PLAN

DIGENE GETS $600,000 CONTRACT TO TEST FOR HPV

EUROPEAN PATENT DISCLOSURES

SOMATIX HOPES FOR NOVEMBER NUPTIAL

GREENWICH RAISES $11.9 MILLION

CROP GENETICS LICENSES USDA BIOPESTICIDES

RESEARCHERS CLOSE IN ON ALZHEIMER'S GENE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...